A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial-Reference-Cited by-同舟云学术

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Published:2020-01-15 Issue:6 Volume:182 Page:1348-1358
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Blauvelt A.¹^ORCID,Papp K.²^ORCID,Gottlieb A.³,Jarell A.⁴,Reich K.⁵⁶^ORCID,Maari C.⁷,Gordon K.B.⁸,Ferris L.K.⁹,Langley R.G.¹⁰,Tada Y.¹¹,Lima R.G.¹²,Elmaraghy H.¹²,Gallo G.¹²,Renda L.¹²,Park S.Y.¹²,Burge R.¹²,Bagel J.¹³,Vender Ronald,Lomaga Mark A.,Delorme Isabelle,Hong Chih‐Ho,Langley Richard L.,Albrecht Lorne,Guenther Lyn,Maari Catherine,Papp Kim,Singh Ohson Kamal K.,Barber Kirk,Lynde Charles,Gupta Aditya,Rosoph Leslie,Gauthier Jean‐Sébastien,Gooderham Melinda,Wasel Norman,Raman Mani,Wiseman Marni,Greenstein David,Jarell Abel,Moon Charles,Clark Lani,Jazayeri Sadra Sasha,Bukhalo Michael,Moore Angela,Hamilton Tiffani K.,Gewirtzman Aron,Hazan Lydie,Crowley Jeffrey,Teller Craig,Zirwas Matthew,Smith Stacy R.,Christine Lee M.,Tyring Stephen,Lee Patricia,Dhawan Sunil,Leonardi Craig,Jesus Amarilis Perez‐De,McFalda Wendy,Frankel Ellen,Yamauchi Paul,Fretzin Scott,Serrao Rocco,Schlesinger Todd,Gottlieb Scott,Jenkin Peter,Gharib Rola,Davis Steven,Nami Navid,Draelos Zoe Diana,Godwin Lloyd,Owen Cindy,Landis Megan,Abramovits William,Sanchez‐Rivera Samuel,Van Voorhees Abby,Fivenson David,Kerdel Francisco,Forman Seth B.,Weinberg Jeffrey,Gonzalez‐Chavez Jose,Boyce Brent,Stein‐Gold Linda,Hudson Charles,Brown Constance,Coggi James,Feser Christina,Forconi Rion,Johnson Sandra,McCune Mark,Green Lawrence,Madkan Vandana,Shipp Dana Maxwell,Gordon Kenneth,Waibel Jill,Soto‐Raices Oscar,Cather Jennifer,Miller Scott,Scott John,Young Douglas,Kaffenberger Jessica,Yokum Kelley,Zook Matthew,Blauvelt Andrew,Truett Artis,Schmieder George,McCracken Gary,McElgunn Patrick,Herrmann James,Suchniak Jeffery M.,Appel James,Barranco Elizabeth,Lee Mark,Bagel Jerry,Osman Lawrence,Cauthen Ashley,Sadick Neil,De La Torre Eneida,Taylor Kelly,Cohen David,Harris Holly Hake,Soung Jennifer,Dimitropoulos Vassilios,Miller Stephen,Barnes Cathy,Jumean‐Haddad Rawan,Bruce Suzanne,Cheung Lawrence,Guenthner Scott,Gaspari Anthony,Laquer Vivian,Krell James M.,Jacobs Shahram,Nahm Walter,Korman Neil,Elewski Boni,Ferris Laura,Duffin Kristina Callis,Pariser David,Johnson Brian,Wallace Paul,Travers Jeffrey,Fried Richard,

Affiliation:

1. Oregon Medical Research Center Portland OR U.S.A.

2. Probity Medical Research, Inc. Waterloo Ontario Canada

3. Department of Dermatology Icahn School of Medicine at Mount Sinai New York NY U.S.A.

4. Northeast Dermatology Associates Portsmouth NH U.S.A.

5. Translational Research in Inflammatory Skin Diseases Institute for Health Services Research in Dermatology and Nursing University Medical Center Hamburg‐Eppendorf Hamburg Germany

6. Skinflammation^® Center Hamburg Germany

7. Innovaderm Research Montreal QC Canada

8. Medical College of Wisconsin Milwaukee WI U.S.A.

9. Department of Dermatology University of Pittsburgh Pittsburgh PA U.S.A.

10. Dalhousie University Halifax Nova Scotia Canada

11. Department of Dermatology Teikyo University School of Medicine Tokyo Japan

12. Eli Lilly and Company Indianapolis IN U.S.A.

13. Psoriasis Treatment Center of Central New Jersey East Windsor NJ U.S.A.

Funder

Eli Lilly and Company

Publisher

Wiley